Literature DB >> 15810090

Changes of ECM and CAM gene expression profile in the cirrhotic liver after HCV infection: analysis by cDNA expression array.

Xin Xu1, Yi-Ming Li, Hong Ji, Chong-Zhi Hou, Ying-Bo Cheng, Fu-Ping Ma.   

Abstract

AIM: We aimed to observe the expression of extracellular matrix (ECM) and cellular adhesion molecules (CAM) in cirrhotic liver tissues after hepatitis C virus (HCV) infection.
METHODS: Twelve patients with post HCV inflammatory liver cirrhosis were selected to evaluate their liver function and other virological, pathological parameters. Then three specimens of cirrhotic patients whose health assessment results and laboratory data were similar and three normal liver specimens explanted from liver grafts prepared for liver transplantation were chosen for investigating gene expression of ECM and CAM using cDNA expression array.
RESULTS: The cDNA array assay revealed 36.7% (36/96) of genes with changes, in which 26.3% (26/96) was up-regulated and 10.1% (10/96) was down-regulated. Integrin (ITGA), collagen (COL), ADAMTS were identified as the characteristic changes of ECM and CAM gene expression levels. ITGA were demonstrated beta1 and beta2 sub-section changed in liver cirrhosis.
CONCLUSION: ECM and CAM play an important role in the progression of liver cirrhosis after HCV infection. The capital mechanism is related to the inflammatory cells infiltration, the activation and transformation of ECM producing cells and the imbalance between production and elimination of ECM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15810090      PMCID: PMC4305793          DOI: 10.3748/wjg.v11.i14.2184

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

Review 1.  The extracellular matrix in multiple sclerosis: an update.

Authors:  R A Sobel
Journal:  Braz J Med Biol Res       Date:  2001-05       Impact factor: 2.590

2.  PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.

Authors:  T Oda; Y O Jung; H S Kim; X Cai; J M López-Guisa; Y Ikeda; A A Eddy
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

3.  Host genetic factors influence disease progression in chronic hepatitis C.

Authors:  E E Powell; C J Edwards-Smith; J L Hay; A D Clouston; D H Crawford; C Shorthouse; D M Purdie; J R Jonsson
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

Review 4.  The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease.

Authors:  E W Raines
Journal:  Int J Exp Pathol       Date:  2000-06       Impact factor: 1.925

Review 5.  Antifibrogenic therapies in chronic HCV infection.

Authors:  I Shimizu
Journal:  Curr Drug Targets Infect Disord       Date:  2001-08

6.  [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].

Authors:  J Kozłowska; T Łoch; J Jabłońska; J Cianciara
Journal:  Przegl Epidemiol       Date:  2001

Review 7.  Impact of oestrogens on the progression of liver disease.

Authors:  Ichiro Shimizu
Journal:  Liver Int       Date:  2003-02       Impact factor: 5.828

Review 8.  Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements?

Authors:  O Znoiko Olga; D Yuschuk Nikolai
Journal:  Curr Pharm Biotechnol       Date:  2003-06       Impact factor: 2.837

9.  Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology.

Authors:  Fiorella Calabrese; Marialuisa Valente; Cinzia Giacometti; Elena Pettenazzo; Luisa Benvegnu; Alfredo Alberti; Angelo Gatta; Patrizia Pontisso
Journal:  J Gastroenterol Hepatol       Date:  2003-11       Impact factor: 4.029

10.  Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.

Authors:  Maria W Smith; Zhaoxia N Yue; Marcus J Korth; Hao A Do; Loreto Boix; Nelson Fausto; Jordi Bruix; Robert L Carithers; Michael G Katze
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

View more
  2 in total

Review 1.  Diagnostic approaches for viruses and prions in stem cell banks.

Authors:  Fernando Cobo; Paloma Talavera; Angel Concha
Journal:  Virology       Date:  2005-12-27       Impact factor: 3.616

2.  Application of molecular diagnostic techniques for viral testing.

Authors:  Fernando Cobo
Journal:  Open Virol J       Date:  2012-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.